α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
| Author | |
|---|---|
| Abstract | :
Attention-deficit/hyperactivity disorder (ADHD) is diagnosed in approximately 2.4% of preschool-age children. Stimulants are recommended as first-line medication treatment. However, up to 25% of preschool-age children with ADHD are treated with α2-adrenergic agonist medications, despite minimal evidence about their efficacy or adverse effects in this age range. |
| Year of Publication | :
2021
|
| Journal | :
JAMA
|
| Volume | :
325
|
| Issue | :
20
|
| Number of Pages | :
2067-2075
|
| Date Published | :
2021
|
| ISSN Number | :
0098-7484
|
| URL | :
https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.6118
|
| DOI | :
10.1001/jama.2021.6118
|
| Short Title | :
JAMA
|
| Download citation |